Guidant News

Guidant Withdraws Defective Xience Stents from Market

At a glance:

Guidant announced the withdrawal of Xience heart stents from the European and Japanese markets after defects were discovered during clinical trials. The company did not disclose the nature of the defects but did note they occurred because of a production problem. They had no reports of injuries to any patients who used the stents, small metal cylinders used to prop open arteries, and they are calling this a "$15 million write-off." Guidant is currently in the process of being acquired by Boston Scientific.

Guidant to withdraw defective stents made for Europe and Japan - International Herald Tribune

No Source - 3/30/2006 8:05 AM

Guidant announced the withdrawal of Xience heart stents from the European and Japanese markets after defects were discovered during clinical trials. The company did not disclose the nature of the defects but did note they occurred because of a production problem. They had no reports of injuries to any patients who used the stents, small metal cylinders used to prop open arteries, and they are calling this a "$15 million write-off." Guidant is currently in the process of being acquired by Bo
 
· Read The Full Guidant Article From No Source -->

· Read All Guidant News Stories -->

Comments On Guidant News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: